Literature DB >> 15309402

Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.

Ioannis Mylonas1, Josef Makovitzky, Anja Fernow, Dagmar-Ulrike Richter, Udo Jeschke, Volker Briese, Bernd Gerber, Klaus Friese.   

Abstract

BACKGROUND: Inhibins (INH) are dimeric glycoproteins, composed of an alpha subunit (INH-alpha) and one of two possible beta subunits (INH-betaA or INH-betaB). They have substantial roles in human reproduction and in endocrine-responsive tumours. Therefore, the aims of this study were to determine the frequency and tissue distribution of INH-alpha, INH-betaA and INH-betaB in normal human endometrium and glandular-cystic endometrial polyps, and polyps caused by tamoxifen use.
MATERIALS AND METHODS: Tissue samples were obtained from women in the proliferative, early secretory and late secretory phase as well as glandular-cystic polyps and endometrial polyps associated with tamoxifen use (n = 5 each). Immunohistochemistry with specific monoclonal antibodies, a semi-quantitative analysis and statistical evaluation was performed.
RESULTS: INH-alpha, INH-betaA and INH-betaB were primarily observed in glandular and luminal epithelial cells, with a variant staining intensity in stromal cells. INH-alpha in glands was significantly higher during the early secretory phase (p < 0.05) and the late secretory phase (p < 0.01) than in the proliferative phase with a significant difference between the early secretory and the late secretory phases (p < 0.01). INH-betaA expression was significantly higher during the late secretory than the proliferative phase (p < 0.05) and the late secretory than the early secretory phase (p < 0.05), with no significant differences for INH-betaB. Glandular-cystic polyps showed significantly lower expression of INH-alpha and INH-betaA than the late secretory endometria (p < 0.05 and p < 0.01 respectively). Additionally, tamoxifen-associated polyps also demonstrated a significantly lower expression of INH-alpha and INH-betaA than late secretory endometria (p < 0.01 and p < 0.01 respectively). No statistical differences were observed between tamoxifen-associated and glandular-cystic polyps. DISCUSSION: INH-alpha, INH-betaA and INH-betaB were expressed in normal endometrium and endometrial polyps. A cyclical expression of INH-alpha and INH-betaA in normal glands may reflect a functional and hormone-dependent role in human endometrium. Significant differences in staining reaction between the late secretory endometria and polyps suggest that this tissue remains in the proliferating state rather than the secretory state. Therefore, endometrial polyps may be tumours of dysregulation with mainly proliferating characteristics, being unable to synchronise with normal endometrium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309402     DOI: 10.1007/s00404-004-0666-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines.

Authors:  Florian Bergauer; Ansgar Brüning; Naim Shabani; Thomas Blankenstein; Julia Jückstock; Darius Dian; Ioannis Mylonas
Journal:  J Mol Histol       Date:  2009-12-24       Impact factor: 2.611

2.  Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue.

Authors:  Ioannis Mylonas; Ansgar Brüning; Naim Shabani; Susanne Kunze; Markus S Kupka
Journal:  Reprod Biol Endocrinol       Date:  2010-11-19       Impact factor: 5.211

3.  Endometrial polyps with increased plasma cells are associated with chronic endometritis in infertility patients: Hysteroscopic findings and post-polypectomy pregnancy rates.

Authors:  Mari Nomiyama; Fumio Yamasaki; Mariko Tokunaga; Yukari Ohbuchi; Naka Sago; Kaoru Arima; Wakako Nishiyama; Mariko Hashiguchi; Kayoko Kojima
Journal:  Reprod Med Biol       Date:  2021-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.